91 related articles for article (PubMed ID: 7139626)
1. Enhanced radiation lethality in partially synchronized solid mouse tumors.
Todoroki T; Koike S; Tsunemoto H; Watanabe I
Cancer Res; 1982 Dec; 42(12):5231-5. PubMed ID: 7139626
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
Pallavicini MG; Gray JW; Folstad LJ
Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
[TBL] [Abstract][Full Text] [Related]
3. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
Fietkau R; Friede H; Maurer-Schultze B
Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397
[TBL] [Abstract][Full Text] [Related]
5. The effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells.
Jones PA; Baker MS; Benedict WF
Cancer Res; 1976 Oct; 36(10):3789-97. PubMed ID: 986242
[TBL] [Abstract][Full Text] [Related]
6. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
Schwartz SA; Morgenstern B; Capizzi RL
Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
[TBL] [Abstract][Full Text] [Related]
7. Increased radiosensitivity of a recurrent murine fibrosarcoma following radiotherapy.
Ando K; Koike S; Ikehira H; Hayata I; Shikita M; Yasukawa M
Jpn J Cancer Res; 1985 Feb; 76(2):99-103. PubMed ID: 3920106
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined treatment with cisplatin and 5-fluorouracil on cell growth and cell cycle kinetics of a mouse ascites tumor growing in vivo.
Lewin F; Skog S; Tribukait B; Ringborg U
In Vivo; 1990; 4(5):277-82. PubMed ID: 2133100
[TBL] [Abstract][Full Text] [Related]
9. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
Grdina DJ; Sigdestad CP; Jovonovich JA
Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
[TBL] [Abstract][Full Text] [Related]
10. [Tumor immunity induced by local radiotherapy].
Yamashita T; Hayakawa Y; Hanajima K; Mochizuki S
Gan No Rinsho; 1983 Oct; 29(13):1506-11. PubMed ID: 6422094
[TBL] [Abstract][Full Text] [Related]
11. Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation.
Hahn GM; Rockwell S; Kallman RF; Gordon LF; Frindel E
Cancer Res; 1974 Feb; 34(2):351-4. PubMed ID: 4810908
[No Abstract] [Full Text] [Related]
12. Cytokinetic properties of asynchronous and cytosine arabinoside perturbed murine tumors measured by simultaneous bromodeoxyuridine/DNA analyses.
Pallavicini MG; Summers LJ; Dolbeare FD; Gray JW
Cytometry; 1985 Nov; 6(6):602-10. PubMed ID: 4064840
[TBL] [Abstract][Full Text] [Related]
13. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation-induced leg contractures in mice.
Hunter N; Milas L
Cancer Res; 1983 Apr; 43(4):1630-2. PubMed ID: 6831410
[TBL] [Abstract][Full Text] [Related]
14. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
15. Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice.
Chu AM; Fowler JF
Cancer Res; 1982 May; 42(5):1943-9. PubMed ID: 7066905
[TBL] [Abstract][Full Text] [Related]
16. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW
Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143
[TBL] [Abstract][Full Text] [Related]
18. Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine.
Boehm TL; Drahovsky D
Cancer Res; 1982 Apr; 42(4):1537-40. PubMed ID: 7060025
[TBL] [Abstract][Full Text] [Related]
19. Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo.
Chiang CS; Syljuäsen RG; Hong JH; Wallis A; Dougherty GJ; McBride WH
Cancer Res; 1997 Sep; 57(18):3899-903. PubMed ID: 9307268
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
